Merck CEO says still confident on cholesterol drug - Reuters
Published by Google Inc. April 28th, 2008 in Google FDA News, Regulatory Affairs Citizen | Merck CEO says still confident on cholesterol drug Reuters - The US Food and Drug Administration issued a non-approvable letter for the medicine designed to raise levels of HDL, or good cholesterol. ... Breat-feeding at its highest rate S&P 500 Leaders and Laggards: Merck, Office Depot Merck shares fall on FDA drug rejection, Abbott shares rise |